Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
British Journal of Haematology|September 29, 2012
Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphomaMonica Else, Ana Marín-Niebla, Fátima de la Cruz, et al.Cancer|October 26, 2005
Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 yearsMonica Else, Rosa Ruchlemer, Nnenna Osuji, et al.Leukemia & Lymphoma|April 21, 2011
Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrenceMonica Else, Claire E Dearden, Estella Matutes, et al.Leukemia & Lymphoma|October 25, 2008
Characterising the TP53-deleted subgroup of chronic lymphocytic leukemia: an analysis of additional cytogenetic abnormalities detected by interphase fluorescence in situ hybridisation and array-based comparative genomic hybridisationHannah C Rudenko, Monica Else, Claire Dearden, et al.Leukemia & Lymphoma|November 21, 2008
Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLLAlison Morilla, David Gonzalez de Castro, Ilaria Del Giudice, et al.British Journal of Haematology|April 7, 2009
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosisMonica Else, Claire E Dearden, Estella Matutes, et al.British Journal of Haematology|June 26, 2009
Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testingAndrew G Bosanquet, Sue M Richards, Rachel Wade, et al.Blood|October 23, 2012
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trialDavid G Oscier, Matthew J J Rose-Zerilli, Nils Winkelmann, et al.Blood|October 17, 2013
CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemiaGillian G Johnson, Ke Lin, Trevor F Cox, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Deletions of CDKN2C in multiple myeloma: biological and clinical implicationsPaola E Leone, Brian A Walker, Matthew W Jenner, et al.Pageof 4